Nobel Winner Shinya Yamanaka: Cell Therapy Is Very Promising For Cancer, Parkinsons, More Forbes
Nobel Winner Shinya Yamanaka: Cell Therapy Is Very Promising For Cancer, Parkinsons, More Forbes
World J Stem Cells. 2015 Mar 26; 7(2): 315328. Dharmendra Kumar, Thirumala R Talluri, Taruna Anand, Wilfried A Kues, Institute of Farm Animal Genetics, Friedrich-Loeffler-Institute, 31535 Mariensee, Germany Dharmendra Kumar, Animal Physiology and Reproduction Division, Central Institute for Research on Buffaloes, Hisar 125001, Haryana, India Thirumala R Talluri, Taruna Anand, National Research Centre on Equines, Hisar 125001, Haryana, India Correspondence to: Dr.
J Korean Neurosurg Soc. 2019 Sep; 62(5): 493501. 1Department of Laboratory Medicine, Korea University Ansan Hospital, Ansan, Korea 2Department of Neurosurgery, Korea University Ansan Hospital, Ansan, Korea 1Department of Laboratory Medicine, Korea University Ansan Hospital, Ansan, Korea 2Department of Neurosurgery, Korea University Ansan Hospital, Ansan, Korea 1Department of Laboratory Medicine, Korea University Ansan Hospital, Ansan, Korea 2Department of Neurosurgery, Korea University Ansan Hospital, Ansan, Korea Received 2018 Dec 7; Revised 2019 Mar 16; Accepted 2019 Apr 22. The generation of human induced pluripotent stem cells (iPSCs) from somatic cells using gene transfer opens new areas for precision medicine with personalized cell therapy and encourages the discovery of essential platforms for targeted drug development
Induced pluripotent stem cells are derived from skin or blood cells that have been reprogrammed back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes. For example, iPSC can be prodded into becoming beta islet cells to treat diabetes, blood cells to create new blood free of cancer cells for a leukemia patient or neurons to treat neurological disorders. Using iPSC technology, center researchers have reprogrammed skin cells into active motor neurons, egg and sperm precursors, liver cells, bone precursors, and blood cells
Unlocking new regenerative pathways in iPS cellderived epicardium for cardiac repair Medical Xpress
Artificial heart made of iPS cells unveiled to press, to be displayed at 2025 Osaka expo - The Mainichi The Mainichi
Trial planned on sparing diabetes patients from insulin injections
Leveraging the power of iPS cell technology to study myeloid neoplasm Medical Xpress
Kyoto University Hospital seeks to treat Type 1 diabetes using iPS cells The Japan Times
Kyoto Hospital to Test Using Ips Cells to Treat Diabetes; Seeks to Reduce Burden of Multiple Daily Insulin Injections The Japan News
Recent Comments